attenuated measles vaccine - Edmonston strain
Trade name: rubeovax
Vaccinewithdrawn
Approved
Mar 1, 1963
Clinical trial activity
25 trials · 40 clinical orgs · 1 marketing orgs
Phase 1
4
Phase 2
5
Phase 3
3
Phase 4
14
Earliest trial started Nov 2, 1999 (NCT00000815)
Timeline
Indications
Approved for
Studied for
- BCG Vaccine · Phase 4
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Chickenpox · Phase 4
- Child · Phase 4
- Diphtheria · Phase 4
- Hand, Foot and Mouth Disease · Phase 4
- Healthy Volunteers · Phase 3
- Hepatitis A · Phase 4
- HIV · Phase 4
- HIV Infections · Phase 2
- Hospitalization · Phase 4
- Malaria · Phase 3
- Malaria Vaccines · Phase 3
- Measles · Phase 4
- Measles Vaccine · Phase 4
- Medulloblastoma · Phase 1
- Meningococcal Infections · Phase 3
- Morbidity · Phase 4
- Mortality · Phase 4
- Mother-Child Relations · Phase 4
- Poliovirus Vaccine, Oral · Phase 4
- Rhabdoid Tumor · Phase 1
- Rotavirus Infections · Phase 4
- Rubella · Phase 1
- Streptococcal Infections · Phase 3
- Tetanus · Phase 4
- Vaccine-Preventable Diseases · Phase 4
- Vaccines · Phase 4
- Whooping Cough · Phase 4
Mechanism of action
- Measles virusImmunity, active
Measles virus immunity, active
Approval history
- withdrawnMar 1, 1963
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109211 ↗
Also known as
- attenuated measles vaccine
- attenuvax
- attenuvax
- attenuvax
- measles, live attenuated
- measles vaccine
- measles virus vaccine
- measles virus vaccine live
- rubeola (measles) vaccine, live attenuated
- rubeola (measles) vaccine, live, attenuated
- rubeola (measles) vaccine, live further attenuated
- rubeovax
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05794230 | Phase 3 | Mar 27, 2023 | Sanofi-Aventis |
| NCT04899765 | Phase 4 | May 20, 2021 | Bandim Health Project, Free University of Brussels, University of Southern Denmark, University of Western Australia |
| NCT04220671 | Phase 4 | Jan 31, 2020 | Bandim Health Project |
| NCT03296410 | Phase 4 | Sep 14, 2017 | Chinese Academy of Medical Sciences, Government of China |
| NCT03330171 | Phase 4 | Apr 10, 2017 | University of the Witwatersrand |
| NCT03170765 | N/A | Mar 14, 2017 | Postgraduate Institute of Medical Education and Research |
| NCT03460002 | Phase 4 | Nov 30, 2016 | Bandim Health Project, Statens Serum Institut |
| NCT02962167 | Phase 1 | Nov 1, 2016 | Mayo Clinic, No More Kids With Cancer, The Matthew Larson Foundation for Pediatric Brain Tumors, University of California, San Francisco, Vyriad, Inc. |
| NCT02943681 | N/A | Oct 1, 2016 | Bandim Health Project |
| NCT02196285 | Phase 1 | Sep 1, 2015 | Bill and Melinda Gates Foundation, Oswaldo Cruz Foundation |
| NCT02286895 | Phase 4 | Oct 1, 2014 | Centre for Vaccine Development, Mali, PATH, University of Maryland |
| NCT01668745 | Phase 4 | May 1, 2013 | Bandim Health Project, Centre de Recherche en Sante de Nouna, Burkina Faso, National Institute for Public Health and the Environment, RIVM, Holland, Navrongo Health Research Centre, Ghana, University of Heidelberg |
| NCT01644721 | Phase 4 | Jul 1, 2012 | Bandim Health Project, Centre de Recherche en Sante de Nouna, Burkina Faso, National Institute for Public Health and the Environment, RIVM, Holland, Navrongo Health Research Centre, Ghana, University of Heidelberg |
| NCT01557699 | Phase 1 | Mar 1, 2012 | Centers for Disease Control and Prevention (CDC), Dr. D. Y. Patil Dental College & Hospital, Serum Institute of India Pvt. Ltd., University of Colorado, Boulder |
| NCT01345240 | Phase 3 | Nov 1, 2011 | GlaxoSmithKline |
| NCT01486355 | Phase 4 | Aug 1, 2011 | Bandim Health Project |
| NCT02724852 | Phase 4 | Jul 1, 2011 | Chiangmai University |
| NCT01306006 | Phase 4 | Feb 1, 2011 | Bandim Health Project, Institudo Nacional de Saude Publica INASA |
| NCT00828022 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2009 | Ben Gurion University |
| NCT00829010 | Phase 3 | Feb 1, 2009 | GlaxoSmithKline |
Showing 20 of 25 trials
Page 1 / 2
Organizations
Research & Development (40)
40 organizations
Page 1 / 2